Article
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
PloS one - 1 Jan 2015
Peyser Noah D, Du Yu, Li Hua, Lui Vivian, Xiao Xiao, Chan Timothy A, Grandis Jennifer R
Abstract excerpt
BACKGROUND: Protein tyrosine phosphatase receptor type D (PTPRD) is a putative tumor suppressor in several cancers including head and neck squamous cell carcinoma (HNSCC). STAT3 is a frequently hyperactivated oncogene in HNSCC. As STAT3 is a direct substrate of PTPRD, we sought to determine the genetic or epigenetic alterations of PTPRD that contribute to overactive STAT3 in HNSCC. METHODS: We analyzed data from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
